Impact of the FreeStyle Libre 2 ® System on Glycaemic Outcomes in Patients with Type 1 Diabetes-Preliminary Study.

Katarzyna RutkowskaAgnieszka Łoś-StegientaMichał BagińskiEwa ZiębaAdrianna BaranMonika Żurawska-KliśMarcin KosińskiKatarzyna Cypryk

Published in: Diagnostics (Basel, Switzerland) (2024)

Short-term use of FSL2 promotes a significant reduction in GMI in patients with more time spent in hyperglycaemia (especially > 250 mg/dL). In this short period of use, no other changes in glycaemic control parameters are observed.

Keyphrases

type diabetes
insulin resistance